ArticleCurrent oncology (Toronto, Ont.)2016

Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in Canada.

P A Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.